Donor immune cells procedure allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy32

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Cells, Cultured Bone Marrow Cells Immune System Pluripotent Stem Cells CD8-Positive T-Lymphocytes Mesenchymal Stromal Cells Bone Marrow Neural Stem Cells T-Lymphocytes, Cytotoxic CD4-Positive T-Lymphocytes Induced Pluripotent Stem Cells Lymphocytes Killer Cells, Natural Multipotent Stem Cells Philadelphia Chromosome T-Lymphocyte Subsets T-Lymphocytes, Regulatory Fetal Blood Fetal Stem Cells Dendritic Cells Spleen B-Lymphocytes Allografts Spermatogonia Blood Cells Cell Line

Organisms11

Transplantation Chimera Cytomegalovirus Mice, Inbred C57BL Herpesvirus 6, Human Mice, Inbred BALB C Herpesvirus 4, Human Mice, SCID Radiation Chimera Mice, Knockout Chimera Mice, Transgenic

Diseases46

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia, Myeloid, Acute Multiple Myeloma Leukemia Cytomegalovirus Infections Leukemia, Myelogenous, Chronic, BCR-ABL Positive Myelodysplastic Syndromes Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma Hepatic Veno-Occlusive Disease Acute Disease Primary Myelofibrosis Anemia, Aplastic Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Lymphoproliferative Disorders Leukemia, Myeloid Hodgkin Disease Infection Lymphoma, Non-Hodgkin Opportunistic Infections Stomatitis Adenoviridae Infections Leukemia, Lymphocytic, Chronic, B-Cell Chronic Disease Lymphoma Epstein-Barr Virus Infections Mycoses Blast Crisis Lymphoma, Follicular Neoplasms Viremia Aspergillosis Philadelphia Chromosome Neoplasm Recurrence, Local Disease Progression Severe Combined Immunodeficiency Disease Models, Animal Postoperative Complications Lymphoma, Mantle-Cell Blood Group Incompatibility Iron Overload Amyloidosis

Chemicals and Drugs47

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antigens, CD34 Antibodies, Neoplasm Cytarabine Benzamides Antineoplastic Agents Fusion Proteins, bcr-abl Receptors, Purinergic P2X5 Pyrimidines Ganciclovir Granulocyte Colony-Stimulating Factor Cyclosporine Piperazines Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antigens, CD Etoposide Benzydamine Antiviral Agents Vincristine Cytokines Antibodies, Monoclonal, Humanized Antigens, Viral Interferon-gamma Stem Cell Factor DNA, Viral Viral Matrix Proteins Isoantigens Carmustine Antigens, Neoplasm fms-Like Tyrosine Kinase 3 Biological Markers Thiotepa Antineoplastic Agents, Alkylating HLA-A2 Antigen Thalidomide Tacrolimus Recombinant Proteins Antifungal Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Bone Marrow Transplantation Treatment Outcome Remission Induction Histocompatibility Testing Lymphocyte Transfusion Retrospective Studies Cord Blood Stem Cell Transplantation Combined Modality Therapy Liver Transplantation Salvage Therapy Lymphocyte Depletion Whole-Body Irradiation Disease-Free Survival Survival Analysis Survival Rate Mesenchymal Stem Cell Transplantation Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Kidney Transplantation Cell Transplantation Follow-Up Studies Prognosis Immunosuppression Flow Cytometry Immunotherapy, Adoptive Heart Transplantation Fatal Outcome Leukocyte Transfusion Lymphocyte Count Immunotherapy Transplantation, Isogeneic Prospective Studies Risk Factors Lung Transplantation Polymerase Chain Reaction Immunophenotyping Actuarial Analysis Organ Transplantation Cytogenetic Analysis Islets of Langerhans Transplantation Incidence Transplantation Clinical Trials as Topic Lymphocyte Activation Cohort Studies Cell Separation Feasibility Studies Reverse Transcriptase Polymerase Chain Reaction Kaplan-Meier Estimate Pancreas Transplantation Multivariate Analysis Viral Load Leukapheresis Pilot Projects Disease Models, Animal Donor Selection Skin Transplantation Transplantation, Heterologous Drug Evaluation Cell Culture Techniques Predictive Value of Tests Bone Marrow Purging Stem Cell Research Transplantation, Heterotopic Fetal Tissue Transplantation Lymphocyte Culture Test, Mixed Life Tables Cell- and Tissue-Based Therapy Case-Control Studies Cell Count Risk Assessment Blood Component Removal Coculture Techniques Immunohistochemistry

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes34

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Virus Activation Histocompatibility Time Factors Chimerism Transplantation Immunology Immunocompromised Host Graft Rejection Cell Differentiation Lymphocyte Count Stem Cell Niche Cell Proliferation T-Cell Antigen Receptor Specificity Lymphocyte Activation Hematopoiesis Philadelphia Chromosome Cell Lineage Cytotoxicity, Immunologic Immune Tolerance Transplantation Tolerance Viral Load Regeneration Drug Resistance, Neoplasm Immunity, Innate Radiation Chimera Signal Transduction Graft vs Host Reaction Cell Survival Phenotype Karyotype Cell Count Immunity, Cellular

Disciplines and Occupations3

Hematology Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care24

Treatment Outcome Retrospective Studies Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Fatal Outcome Prospective Studies Risk Factors Actuarial Analysis Incidence Clinical Trials as Topic Cohort Studies Feasibility Studies Kaplan-Meier Estimate Multivariate Analysis Pilot Projects Donor Selection Predictive Value of Tests Tissue and Organ Procurement Life Tables Case-Control Studies Risk Assessment Age Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Hematologic Neoplasms Tissue Donors Transplantation Chimera Stem Cells Bone Marrow Transplantation Graft vs Leukemia Effect Treatment Outcome Myeloablative Agonists Busulfan Remission Induction Vidarabine Recurrence Graft vs Tumor Effect Graft Survival Histocompatibility Testing Lymphocyte Transfusion Immunosuppressive Agents Leukemia, Myeloid, Acute Retrospective Studies Multiple Myeloma Leukemia Siblings Cord Blood Stem Cell Transplantation Cytomegalovirus Infections Combined Modality Therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive Hematopoietic Stem Cells Minor Histocompatibility Antigens Liver Transplantation Salvage Therapy Lymphocyte Depletion Whole-Body Irradiation Disease-Free Survival Survival Analysis Antilymphocyte Serum Myelodysplastic Syndromes Survival Rate Virus Activation Histocompatibility Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma T-Lymphocytes Time Factors Melphalan Chimerism Hepatic Veno-Occlusive Disease Mesenchymal Stem Cell Transplantation Cytomegalovirus Cyclophosphamide Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Living Donors Acute Disease Kidney Transplantation Cell Transplantation HLA Antigens Follow-Up Studies Primary Myelofibrosis Anemia, Aplastic Embryonic Stem Cells Prognosis Hematologic Diseases Leukemia, Myeloid, Accelerated Phase Immunosuppression Blood Donors Transplantation Immunology Antigens, CD34 Antibodies, Neoplasm Roseolovirus Infections Cytarabine Immunocompromised Host Benzamides Adult Stem Cells Antineoplastic Agents Lymphoproliferative Disorders Leukemia, Myeloid Graft Rejection Fusion Proteins, bcr-abl Receptors, Purinergic P2X5 Hodgkin Disease Flow Cytometry Pyrimidines Infection Nuclear Family Immunotherapy, Adoptive Ganciclovir Granulocyte Colony-Stimulating Factor Cell Differentiation Heart Transplantation Cyclosporine Piperazines Lymphoma, Non-Hodgkin Fatal Outcome

No FAQ available that match "donor immune cells procedure allogeneic stem cell transplantation"